Methods related to denosumab

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9695244
APP PUB NO 20150246974A1
SERIAL NO

14403828

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the characterization and production of denosumab.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MOMENTA PHARMACEUTICALS INC1125 TRENTON-HARBOURTON ROAD TITUSVILLE NJ 08560

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bosques, Carlos J Arlington, US 82 500
Collins, Brian Edward Arlington, US 32 280
Kaundinya, Ganesh Bedford, US 20 50
Robblee, John Newton, US 21 23

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 4, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 4, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00